CLINICAL_TRIALS
trial_result
· 2021-10-26
Clinical Trial Update: Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism [Phase 4]
Summary
Phase 4 trial evaluating low-dose tenecteplase for patients with pulmonary embolism diagnosed with COVID-19; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Pulmonary Embolism, COVID | Phase 4 | Status: TERMINATED | Results posted: 2021-10-26